We report for the first time that c-Met confers radioresistance in HNSCC via plexin domain containing 2 (PLXDC2), a transmembrane receptor for pigment epithelium-derived factor, which in turn triggers cancer cell plasticity by promoting EMT and enrichment of dedifferentiated cells with CSC-like properties. Here, PLXDC2 is linked to cancer.